These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25901678)

  • 21. Prognostic relevance of p53 mutation in colorectal carcinoma.
    Ofner D; Schmid KW P
    Gastroenterology; 1994 Nov; 107(5):1571-2. PubMed ID: 7926526
    [No Abstract]   [Full Text] [Related]  

  • 22. p53 mutations in primary colorectal adenocarcinomas and liver metastases.
    Yao J; Goh HS; Smith DR
    Br J Surg; 1996 Sep; 83(9):1245-6. PubMed ID: 8983617
    [No Abstract]   [Full Text] [Related]  

  • 23. Is there a role for routine p53 testing in colorectal cancer?
    Hoff PM
    J Clin Oncol; 2005 Oct; 23(30):7395-6. PubMed ID: 16186590
    [No Abstract]   [Full Text] [Related]  

  • 24. [Invasiveness and metastasis in colorectal cancer: P53 gene alteration associated with hepatic metastasis].
    Fushida S; Miwa K
    Nihon Rinsho; 2003 Sep; 61 Suppl 7():107-10. PubMed ID: 14574865
    [No Abstract]   [Full Text] [Related]  

  • 25. [Expression of p53 and bcl-2 in colorectal adenomas and carcinomas].
    Sundblad AS; Chumbita RL; Zoppi JA
    Medicina (B Aires); 1997; 57(6):662-6. PubMed ID: 9674186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aberrant P53 expression lacks prognostic or predictive significance in colorectal cancer: results from the VICTOR trial.
    McGregor MJ; Fadhil W; Wharton R; Yanagisawa Y; Presz M; Pritchard A; Womack C; Dutton S; Kerr RS; Kerr DJ; Johnstone EC; Ilyas M
    Anticancer Res; 2015 Mar; 35(3):1641-5. PubMed ID: 25750322
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Usefulness of analysis of p53 alteration and observation of surface microstructure for diagnosis of ulcerative colitis-associated colorectal neoplasia.
    Fujii S; Fujimori T; Chiba T
    J Exp Clin Cancer Res; 2003 Mar; 22(1):107-15. PubMed ID: 12725330
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [p53 mutations and protein overexpression in primary colorectal cancer and its liver metastasis].
    Yang Y; Xia Q; Lian F
    Zhonghua Zhong Liu Za Zhi; 1999 Mar; 21(2):114-8. PubMed ID: 11776850
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Systematic review and meta-analysis of the association between P53 codon 72 polymorphism and colorectal cancer.
    Tang NP; Wu YM; Wang B; Ma J
    Eur J Surg Oncol; 2010 May; 36(5):431-8. PubMed ID: 20363586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of telomerase and its hTERT messenger in colorectal cancer.
    Boldrini L; Faviana P; Gisfredi S; Donati V; Zucconi Y; Ursino S; Simi P; Baldinotti F; Berti P; Galleri D; Materazzi G; Basolo F; Miccoli P; Pingitore R; Fontanini G
    Oncol Rep; 2004 Feb; 11(2):395-400. PubMed ID: 14719074
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [A study on the mutation of P53 and K-ras gene in colorectal adenomas and colorectal carcinomas].
    Xu W; Cheng Y; Shen XF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2012 Nov; 43(6):821-6. PubMed ID: 23387205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Implication of vascular endothelial growth factor and p53 status for angiogenesis in noninvasive colorectal carcinoma.
    Kondo Y; Arii S; Furutani M; Isigami S; Mori A; Onodera H; Chiba T; Imamura M
    Cancer; 2000 Apr; 88(8):1820-7. PubMed ID: 10760758
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p53 and p53-regulated genes in bladder cancer.
    Crew JP; Jones A
    BJU Int; 1999 Mar; 83(4):529-30. PubMed ID: 10210595
    [No Abstract]   [Full Text] [Related]  

  • 34. p53 tumor suppressor gene mutations predict decreased survival of patients with sporadic colorectal carcinoma.
    Kahlenberg MS; Stoler DL; Rodriguez-Bigas MA; Weber TK; Driscoll DL; Anderson GR; Petrelli NJ
    Cancer; 2000 Apr; 88(8):1814-9. PubMed ID: 10760757
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Significance of p53 gene abnormalities in carcinogenesis of human gastrointestinal tract].
    Tahara E; Yokozaki H
    Nihon Geka Gakkai Zasshi; 1992 Sep; 93(9):940-3. PubMed ID: 1470160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genetic changes in the genesis of gastrointestinal carcinoma.
    Blin N; Seitz G; Theisinger B; Schüder G; Welter C
    Endoscopy; 1992 Nov; 24(9):782-4. PubMed ID: 1468397
    [No Abstract]   [Full Text] [Related]  

  • 37. Fish detected p53 deletion and N-MYC amplification in colorectal cancer.
    Ozakyol A; Ozdemir M; Artan S
    Hepatogastroenterology; 2006; 53(68):192-5. PubMed ID: 16608022
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Adenovirus-mediated p53 gene transfer inhibits growth of human tumor cells expressing mutant p53 protein.
    Harris MP; Sutjipto S; Wills KN; Hancock W; Cornell D; Johnson DE; Gregory RJ; Shepard HM; Maneval DC
    Cancer Gene Ther; 1996; 3(2):121-30. PubMed ID: 8729911
    [TBL] [Abstract][Full Text] [Related]  

  • 39. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Penclomedine-induced DNA fragmentation and p53 accumulation correlate with reproductive cell death in colorectal carcinoma cells with altered p53 status.
    Rakovitch E; Mellado W; Hall EJ; Sawant SG; Geard CR; Newman RA; Pandita TK
    Oncol Rep; 1999; 6(1):161-5. PubMed ID: 9864421
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.